Pharmacovigilance Global Market Opportunities And Strategies To 2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	305 Pages	The Business Research Company	November, 2023	BRC18306119

Best Price Guarantee
Price	from $5,000
Length	305 Pages
Publisher	The Business Research Company
Published Date	November, 2023
SKU	BRC18306119

Pharmacovigilance Global Market Opportunities And Strategies To 2032

Including: 1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining2) By Service Provider: In-House; Contract Outsourcing3) By End-User: Hospitals; Pharmaceutical Companies4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV5) By Process Flow: Case Data Management; Signal Detection; Risk Management SystemCovering: IQVIA; Cognizant; ICON Plc; Accenture plc; PAREXEL International Corporation.

Pharmacovigilance Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmacovigilance market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest-growing market for pharmacovigilance? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider pharmacovigilance market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics: Brief introduction to the segmentations covered in the market, definitions and explanations about the pharmacovigilance market.
Key Trends: Highlights the major trends shaping the global pharmacovigilance market. This section also highlights likely future developments in the market.
Macro Economic Scenario: The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pharmacovigilance market.
Global Market Size And Growth: Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis: Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.
Market Segmentation: Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by type, by service provider, by end user, by clinical trial phases and by process flow in the market.
Regional Market Size And Growth: Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Key Mergers And Acquisitions: Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies: Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations: This section Includes recommendations for pharmacovigilance providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining

2) By Service Provider: In-House; Contract Outsourcing

3) By End-User: Hospitals; Pharmaceutical Companies; Other End-Users

4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV

5) By Process Flow: Case Data Management; Signal Detection; Risk Management System

Companies Mentioned: IQVIA; Cognizant; ICON Plc.; Accenture plc; PAREXEL International Corporation

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmacovigilance indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; pharmacovigilance market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics: 6.1. General Market Definition; 6.2. Summary; 6.3. Pharmacovigilance Market Definition And Segmentations; 6.4. Market Segmentation By Type; 6.4.1. Spontaneous Reporting; 6.4.2. Intensified ADR Reporting; 6.4.3. Targeted Spontaneous Reporting; 6.4.4. Cohort Event Monitoring; 6.4.5. EHR Mining; 6.5. Market Segmentation By Service Provider; 6.5.1. In-House; 6.5.2. Contract Outsourcing; 6.6. Market Segmentation By Process Flow; 6.6.1. Case Data Management; 6.6.2. Signal Detection; 6.6.3. Risk Management System; 6.7. Market Segmentation By Clinical Trial Phases; 6.7.1. Preclinical; 6.7.2. Phase I; 6.7.3. Phase II; 6.7.4. Phase III; 6.7.5. Phase IV; 6.8. Market Segmentation By End User; 6.8.1. Hospitals; 6.8.2. Pharmaceutical Companies; 6.8.3. Other End Users
7. Pharmacovigilance Market - Macro Economic Scenario: 7.1. COVID-19 Impact On The Pharmacovigilance Market; 7.2. Russia-Ukraine War Impact On The Pharmacovigilance Market; 7.3. Impact Of High Inflation On The Pharmacovigilance Market
8. Major Market Trends: 8.1. Increasing Investments; 8.2. Focus On Artificial Intelligence; 8.3. Focus On Innovative Platforms; 8.4. Focus On Innovative Cloud-Based Systems; 8.5. Strategic Mergers And Acquisitions
9. Global Market Size and Growth: 9.1. Market Size; 9.2. Historic Market Growth, 2017 – 2022, Value ($ Million); 9.2.1. Market Drivers 2017 – 2022; 9.2.2. Market Restraints 2017 – 2022; 9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 9.3.1. Market Drivers 2022 – 2027; 9.3.2. Market Restraints 2022 – 2027
10. Global Pharmacovigilance Market Segmentation: 10.1. Global Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 10.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 10.3. Global Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 10.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 10.5. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Pharmacovigilance Market, Regional and Country Analysis: 11.1. Global Pharmacovigilance Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.2. Global Pharmacovigilance Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Asia-Pacific Market: 12.1. Summary; 12.2. Market Overview; 12.2.1. Region Information; 12.2.2. Market Information; 12.2.3. Background Information; 12.2.4. Government Initiatives; 12.2.5. Regulations; 12.2.6. Regulatory Bodies; 12.2.7. Major Associations; 12.2.8. Taxes Levied; 12.2.9. Corporate Tax Structure; 12.2.10. Investments; 12.2.11. Major Companies; 12.3. Asia-Pacific Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.4. Asia-Pacific Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.5. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.6. Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.7. Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.8. Asia-Pacific Pharmacovigilance Market: Country Analysis; 12.9. China Market; 12.10. Summary; 12.11. Market Overview; 12.11.1. Country Information; 12.11.2. Market Information; 12.11.3. Background Information; 12.11.4. Government Initiatives; 12.11.5. Regulations; 12.11.6. Regulatory Bodies; 12.11.7. Major Associations; 12.11.8. Taxes Levied; 12.11.9. Corporate Tax Structure; 12.11.10. Investments; 12.11.11. Major Companies; 12.12. China Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.13. China Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.14. China Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.15. China Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.16. China Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.17. India Market; 12.18. India Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.19. India Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.20. India Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.21. India Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.22. India Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.23. Japan Market; 12.24. Japan Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.25. Japan Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.26. Japan Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.27. Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.28. Japan Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.29. Australia Market; 12.30. Australia Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.31. Australia Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.32. Australia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.33. Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.34. Australia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.35. Indonesia Market; 12.36. Indonesia Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.37. Indonesia Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.38. Indonesia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.39. Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.40. Indonesia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.41. South Korea Market; 12.42. South Korea Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.43. South Korea Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.44. South Korea Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.45. South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.46. South Korea Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Western Europe Market: 13.1. Summary; 13.2. Market Overview; 13.2.1. Region Information; 13.2.2. Market Information; 13.2.3. Background Information; 13.2.4. Government Initiatives; 13.2.5. Regulations; 13.2.6. Regulatory Bodies; 13.2.7. Major Associations; 13.2.8. Taxes Levied; 13.2.9. Corporate Tax Structure; 13.2.10. Investments; 13.2.11. Major Companies; 13.3. Western Europe Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.4. Western Europe Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.5. Western Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.6. Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.7. Western Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.8. Western Europe Pharmacovigilance Market: Country Analysis; 13.9. UK Market; 13.10. UK Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.11. UK Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.12. UK Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.13. UK Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.14. UK Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.15. Germany Market; 13.16. Germany Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.17. Germany Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.18. Germany Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.19. Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.20. Germany Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.21. France Market; 13.22. France Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.23. France Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.24. France Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.25. France Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.26. France Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. Eastern Europe Market: 14.1. Summary; 14.2. Market Overview; 14.2.1. Region Information; 14.2.2. Market Information; 14.2.3. Background Information; 14.2.4. Government Initiatives; 14.2.5. Regulations; 14.2.6. Regulatory Bodies; 14.2.7. Major Associations; 14.2.8. Taxes Levied; 14.2.9. Corporate Tax Structure; 14.2.10. Investments; 14.2.11. Major Companies; 14.3. Eastern Europe Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 14.4. Eastern Europe Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 14.5. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.6. Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.7. Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.8. Eastern Europe Pharmacovigilance Market: Country Analysis; 14.9. Russia Market; 14.10. Russia Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 14.11. Russia Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 14.12. Russia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.13. Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.14. Russia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. North America Market: 15.1. Summary; 15.2. Market Overview; 15.2.1. Region Information; 15.2.2. Market Information; 15.2.3. Background Information; 15.2.4. Government Initiatives; 15.2.5. Regulations; 15.2.6. Regulatory Bodies; 15.2.7. Major Associations; 15.2.8. Taxes Levied; 15.2.9. Corporate Tax Structure; 15.2.10. Investments; 15.2.11. Major Companies; 15.3. North America Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 15.4. North America Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 15.5. North America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.6. North America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.7. North America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.8. North America Pharmacovigilance Market: Country Analysis; 15.9. USA Market; 15.10. Summary; 15.11. Market Overview; 15.11.1. Country Information; 15.11.2. Market Information; 15.11.3. Background Information; 15.11.4. Government Initiatives; 15.11.5. Regulations; 15.11.6. Regulatory Bodies; 15.11.7. Major Associations; 15.11.8. Taxes Levied; 15.11.9. Corporate Tax Structure; 15.11.10. Investments; 15.11.11. Major Companies; 15.12. USA Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 15.13. USA Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 15.14. USA Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.15. USA Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.16. USA Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. South America Market: 16.1. Summary; 16.2. Market Overview; 16.2.1. Region Information; 16.2.2. Market Information; 16.2.3. Background Information; 16.2.4. Government Initiatives; 16.2.5. Regulations; 16.2.6. Regulatory Bodies; 16.2.7. Major Associations; 16.2.8. Taxes Levied; 16.2.9. Corporate Tax Structure; 16.2.10. Major Companies; 16.3. South America Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 16.4. South America Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 16.5. South America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.6. South America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.7. South America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.8. South America Pharmacovigilance Market: Country Analysis; 16.9. Brazil Market; 16.10. Brazil Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 16.11. Brazil Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 16.12. Brazil Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.13. Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.14. Brazil Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Middle East Market: 17.1. Summary; 17.2. Market Overview; 17.2.1. Region Information; 17.2.2. Market Information; 17.2.3. Background information; 17.2.4. Government Initiatives; 17.2.5. Regulations; 17.2.6. Regulatory Bodies; 17.2.7. Major Associations; 17.2.8. Taxes Levied; 17.2.9. Corporate Tax Structure; 17.2.10. Investments; 17.2.11. Major Companies; 17.3. Middle East Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 17.4. Middle East Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 17.5. Middle East Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 17.6. Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 17.7. Middle East Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Africa Market: 18.1. Summary; 18.2. Market Overview; 18.2.1. Region Information; 18.2.2. Market Information; 18.2.3. Background Information; 18.2.4. Government Initiatives; 18.2.5. Regulations; 18.2.6. Regulatory Bodies; 18.2.7. Major Associations; 18.2.8. Taxes Levied; 18.2.9. Corporate Tax Structure; 18.2.10. Investments; 18.2.11. Major Companies; 18.3. Africa Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 18.4. Africa Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 18.5. Africa Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 18.6. Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 18.7. Africa Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
19. Competitive Landscape and Company Profiles: 19.1. Company Profiles; 19.2. IQVIA Holdings, Inc; 19.2.1. Company Overview; 19.2.2. Products And Services; 19.2.3. Business Strategy; 19.2.4. Financial Overview; 19.3. Cognizant Technology Solutions Corporation; 19.3.1. Company Overview; 19.3.2. Products And Services; 19.3.3. Business Strategy; 19.3.4. Financial Overview; 19.4. ICON Plc; 19.4.1. Company Overview; 19.4.2. Products And Services; 19.4.3. Business Strategy; 19.4.4. Financial Overview; 19.5. Accenture plc; 19.5.1. Company Overview; 19.5.2. Products And Services; 19.5.3. Business Strategy; 19.5.4. Financial Overview; 19.6. PAREXEL International Corporation; 19.6.1. Company Overview; 19.6.2. Products And Services; 19.6.3. Financial Overview
20. Key Mergers And Acquisitions: 20.1. AmerisourceBergen Acquired Pharma Lex; 20.2. Clinigen Limited Acquired Drug Safety Navigator Inc; 20.3. Drug Safety and Pharmacovigilance Services Solutions (DSS) Acquired MyMeds&Me; 20.4. TriNetX Acquired Advera Health Analytics; 20.5. Stanley Capital Partners Acquired Drug Safety and Pharmacovigilance Services Solutions; 20.6. Ergomed plc Acquired Ashfield Pharmacovigilance Inc
21. Opportunities And Strategies: 21.1. Global Pharmacovigilance Market In 2027 – Countries Offering Most New Opportunities; 21.2. Global Pharmacovigilance Market In 2027 – Segments Offering Most New Opportunities; 21.3. Global Pharmacovigilance Market In 2027 – Growth Strategies; 21.3.1. Market Trend Based Strategies; 21.3.2. Competitor Strategies
22. Pharmacovigilance Market, Conclusions And Recommendations: 22.1. Conclusions; 22.2. Recommendations; 22.2.1. Product; 22.2.2. Place; 22.2.3. Price; 22.2.4. Promotion; 22.2.5. People
23. Appendix: 23.1. Market Data Sources; 23.2. Research Methodology; 23.3. Currencies; 23.4. The Business Research Company; 23.5. Copyright and Disclaimer